USPTO serial 78316832
SPREMA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- BROWN, BRIAN
- Law office
- TMEG LAW OFFICE 105 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with SPREMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Beaconsfield, GB
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | In your office action, you stated: 'And with pharmaceutical preparations and similar substances, the applicant must specify, the disease, condition or ailment that the goods are used to treat; TMEP §§1402;01 and 1402;03(a); In addition, the applicant must specify what "gemmotherapeutic" means; As a suggestion therefore, the applicant may adopt the following identification, if accurate: Pharmaceutical and veterinary preparations, namely, herbal and homeopathic preparations and substances used to treat applicant must specify the condition or disease to be treated, e;g;, cancer, indigestion, diabetes, in International Class 005'; The suggested identification is certainly accurate and could be used as such; However, to be more precise, gemmotherapy is a branch of herbal medicine that uses remedies made from the buds and young shoots of trees and shrubs, macerated in alcohol and glycerin and prepared in the 1DH homeopathic potency; This is what the word 'gemmotherapeutic' derives from - it is the adjective from the term 'gemmotherapy'; Gemmotherapy is widely used in parts of Europe but at present is little known in the USA - a search on the website will however reveal several sites that sell these products in America, as well as further information about the therapy itself; If possible, I would therefore like to include the term 'gemmotherapeutic' in the listing of goods; However, if it causes too many problems, it should be left out; Abies pectinata: osteoporosis, growing problems Acer campestris: gallstones, high blood pressure Actinidia chinensis: rheumatoid arthritis Aesculus hippocastanum: haemorrhoids Ailanthus altissima, buds: ulceration, sinusitis Ailanthus altissima, bark of young roots: dysentery Alnus glutinosa: strokes Alnus incana: fibrocystic breasts Ampelopsis veitchii: rheumatoid arthritis Berberis vulgaris: detoxification of liver and gallbladder Betula pubescens, bark of young roots: diuretic Betula pubescens, buds: detoxification of liver, gout Betula pubescens, catkins: low libido Betula pubescens, rootlets: raised cholesterol, diuretic Betula verrucosa, buds: rheumatism, fibrocystic breasts Betula verrucosa, sap: gout, kidney stones Betula verrucosa, seeds: memory loss Buddleja davidii: visual disturbances Calluna vulgaris: urinary tract infections Carpinus betulus: sinusitis Castanea vesca: haemorrhoids Cedrus libani: dry skin Cercis siliquastrum: thrombosis Citrus limonum, bark: angina Citrus limonum, buds: hyperacidity Cornus sanguinea: thrombosis Coryllus avellana: emphysema Crataegus oxycantha: angina Fagus sylvatica: water retention Ficus carica, buds: hyperacidity Ficus carica, rootlets: constipation Filipendula ulmaria: arthritis Fraxinus excelsior: glaucoma Fraxinus ornus: impotence Ginkgo biloba: strokes Hedera helix: obesity Hippophae rhamnoides: low resistance Ilex aquifolium: kidney deficiency Juglans regia: eczema Juniperus communis: liver problems Laurus nobilis: disorders of the gonads Ligustrum vulgare: bronchitis Lonicera nigra: hepatitis Magnolia denudata: upper respiratory tract infections Morus nigra: diabetes Olea europaea: hypertension Ostrya carpinifolia: sinusitis Pinus montana: osteoarthritis, rheumatism Pinus sylvestris: arthrosis Platanus orientalis: acne Populus nigra: thrombophlebitis Prunus amygdalus: hypertension Quercus pedunculata, buds: physical debility Quercus pedunculata, acorns: sexual debility Quercus pedunculata, catkins: loss of libido Quercus pedunculata, rootlets: bedsores, eczema Ribes nigrum: adrenal insufficiency Rosa canina: inflammations Rosmarinus officinalis: cirrhosis of the liver Rubus fruticosus: problems of the gonads Rubus idaeus: inflammation of the ovaries Salix alba, bark: arthritis Salix alba, buds: insomnia Salix alba, catkins: amenorrhoea Sanguisorba officinalis: diarrhoea Secale cereale: hepatitis Sequoia giganteum: prostatitis Silybum marianum: liver problems Sorbus domestica: venous insufficiency Sorbus torminalis: menopausal problems Syringa vulgaris: angina Tamarix gallica: problems of the spleen Thymus vulgaris: high cholesterol Tilia tomentosa: anxiety, insomnia Ulmus campestris: eczema, acne Vaccinium myrtillus: fragile capillaries Vaccinium vitis idaea: diarrhoea Viburnum lantana: asthma Vitis vinifera: arthritis Zea mays: heart attack Zizyphus jujuba, buds: insomnia, anxiety Zizyphus jujuba, seeds: memory and concentration loss | ACTIVE | Aug 2, 2003 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 20, 2006 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 17, 2006 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 19, 2005 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 19, 2005 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 18, 2005 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 8, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 8, 2005 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 14, 2005 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 14, 2005 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 25, 2005 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Feb 9, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 9, 2005 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 9, 2005 | PETG | PETITION TO REVIVE-GRANTED | — |
| Feb 9, 2005 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Dec 9, 2004 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 9, 2004 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 17, 2004 | EMRV | EMAIL RECEIVED | — |
| May 13, 2004 | UNPR | UNRESPONSIVE/DUPLICATE PAPER RECEIVED | — |
| May 12, 2004 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 12, 2004 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 5, 2003 | NWAP | NEW APPLICATION ENTERED | — |